Lexeo Therapeutics, Inc. (LXEO) stock forecast and price target
Price $2.87 · data as of November 13, 2026
12-month price target
Average target$20.67
Upside / downside+620.1%
Analysts9
ConsensusStrong buy
Low $9.00Average $20.67High $30.00
Gold marker: average target · white marker: today’s price ($2.87)
Analyst ratings
Strong buy 2Buy 7Hold 0Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-1.20 | +37.8% | $0 |
| Next fiscal year ends December 31, 2027 | $-1.37 | −13.8% | $0 |
| Quarter after ends December 31, 2026 | $-0.34 | −22.8% | $0 |
Consensus of the analysts covering Lexeo Therapeutics, updated daily. In the last 30 days 2 estimates were raised and 3 lowered.
Frequently asked questions
What is the Lexeo Therapeutics stock price target?
The average 12-month target from 9 analysts is $20.67, 620.1% above the current price of $2.87 Targets range from $9.00 to $30.00.
Is Lexeo Therapeutics a buy according to analysts?
The consensus rating is “Strong buy” (2 strong buy, 7 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Lexeo Therapeutics expected to earn?
Analysts expect EPS of $-1.20 for the fiscal year ending December 31, 2026 and $-1.37 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.